Yanina Balabanova

3.4k total citations · 1 hit paper
59 papers, 2.0k citations indexed

About

Yanina Balabanova is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Yanina Balabanova has authored 59 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Infectious Diseases, 38 papers in Epidemiology and 15 papers in Surgery. Recurrent topics in Yanina Balabanova's work include Tuberculosis Research and Epidemiology (37 papers), Mycobacterium research and diagnosis (22 papers) and Pneumonia and Respiratory Infections (15 papers). Yanina Balabanova is often cited by papers focused on Tuberculosis Research and Epidemiology (37 papers), Mycobacterium research and diagnosis (22 papers) and Pneumonia and Respiratory Infections (15 papers). Yanina Balabanova collaborates with scholars based in United Kingdom, Germany and Russia. Yanina Balabanova's co-authors include Francis Drobniewski, Vladyslav Nikolayevskyy, Ivan Fedorin, Olga Ignatyeva, Sergey Nejentsev, Irina Kontsevaya, Timothy J. Brown, Nicola Casali, Rolf D. Horstmann and Julian Parkhill and has published in prestigious journals such as Nature Genetics, PLoS ONE and Genome Research.

In The Last Decade

Yanina Balabanova

59 papers receiving 2.0k citations

Hit Papers

Evolution and transmission of drug-resistant tuberculosis... 2014 2026 2018 2022 2014 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Evolution and transmission of drug-resistant tuberculosis in a Russian population
    2014 350 citations Nicola Casali, Vladyslav Nikolayevskyy et al. profile →

Peers

Yanina Balabanova
A. Kochi Switzerland
Martin Dedicoat United Kingdom
M. Cristina Gutiérrez France
Işık Somuncu Johansen Denmark
Brett Leav United States
Vladyslav Nikolayevskyy United Kingdom
Alice Zwerling Canada
Satoshi Mitarai Japan
Moisés Palaci Brazil
Alphonse Okwera Uganda
A. Kochi Switzerland
Yanina Balabanova
Citations per year, relative to Yanina Balabanova Yanina Balabanova (= 1×) peers A. Kochi

Countries citing papers authored by Yanina Balabanova

Since Specialization
Citations

This map shows the geographic impact of Yanina Balabanova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanina Balabanova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanina Balabanova more than expected).

Fields of papers citing papers by Yanina Balabanova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanina Balabanova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanina Balabanova. The network helps show where Yanina Balabanova may publish in the future.

Co-authorship network of co-authors of Yanina Balabanova

This figure shows the co-authorship network connecting the top 25 collaborators of Yanina Balabanova. A scholar is included among the top collaborators of Yanina Balabanova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanina Balabanova. Yanina Balabanova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruigómez, Ana, Tania Schink, Ron M. C. Herings, et al.. (2024). Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries. PLoS ONE. 19(3). e0298596–e0298596. 1 indexed citations
2.
Linder, Marie, Anders Ekbom, Gunnar Brobert, et al.. (2024). Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study. Journal of Thrombosis and Thrombolysis. 57(6). 973–983. 1 indexed citations
3.
Swart, Karin M. A., Yanina Balabanova, Gunnar Brobert, et al.. (2023). Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands. Drugs - Real World Outcomes. 10(2). 215–224. 1 indexed citations
4.
Ebert, Natalie, Alice Schneider, Dörte Huscher, et al.. (2023). Incidence of hospital-acquired acute kidney injury and trajectories of glomerular filtration rate in older adults. BMC Nephrology. 24(1). 226–226. 6 indexed citations
5.
6.
Balabanova, Yanina, et al.. (2022). Renal decline in patients with non-valvular atrial fibrillation treated with rivaroxaban or warfarin: A population-based study from the United Kingdom. International Journal of Cardiology. 352. 165–171. 10 indexed citations
7.
8.
Rodrı́guez, Luis A. Garcı́a, Mari‐Ann Wallander, Leif Friberg, et al.. (2020). Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice. Expert Opinion on Drug Safety. 19(11). 1513–1520. 4 indexed citations
9.
Rodrı́guez, Luis A. Garcı́a, Mar Martín‐Pérez, Pareen Vora, et al.. (2019). Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK. BMJ Open. 9(9). e031341–e031341. 27 indexed citations
10.
11.
Kontsevaya, Irina, Vladyslav Nikolayevskyy, Olga Ignatyeva, et al.. (2016). Tuberculosis cases caused by heterogeneous infection in Eastern Europe and their influence on outcomes. Infection Genetics and Evolution. 48. 76–82. 12 indexed citations
12.
Balabanova, Yanina, Yvonne Deleré, Hendrik Wilking, et al.. (2013). Serological Evidence of Asymptomatic Infections during Escherichia coli O104:H4 Outbreak in Germany in 2011. PLoS ONE. 8(9). e73052–e73052. 11 indexed citations
13.
Kontsevaya, Irina, et al.. (2012). Diagnostic Accuracy of the GenoType MTBDR sl Assay for Rapid Diagnosis of Extensively Drug-Resistant Tuberculosis in HIV-Coinfected Patients. Journal of Clinical Microbiology. 51(1). 243–248. 18 indexed citations
14.
Casali, Nicola, Vladyslav Nikolayevskyy, Yanina Balabanova, et al.. (2012). Microevolution of extensively drug-resistant tuberculosis in Russia. Genome Research. 22(4). 735–745. 141 indexed citations
15.
Balabanova, Yanina, Edita Davidavičienė, Richard Hooper, et al.. (2011). Survival of drug resistant tuberculosis patients in Lithuania: retrospective national cohort study. BMJ Open. 1(2). e000351–e000351. 35 indexed citations
16.
Balabanova, Yanina, et al.. (2011). Analysis of undiagnosed tuberculosis-related deaths identified at post-mortem among HIV-infected patients in Russia: a descriptive study. BMC Infectious Diseases. 11(1). 276–276. 7 indexed citations
17.
Balabanova, Yanina, Francis Drobniewski, Vladyslav Nikolayevskyy, et al.. (2009). An Integrated Approach to Rapid Diagnosis of Tuberculosis and Multidrug Resistance Using Liquid Culture and Molecular Methods in Russia. PLoS ONE. 4(9). e7129–e7129. 46 indexed citations
18.
Dávila, Sonia, Martin L. Hibberd, Edhyana Sahiratmadja, et al.. (2008). Genetic Association and Expression Studies Indicate a Role of Toll-Like Receptor 8 in Pulmonary Tuberculosis. PLoS Genetics. 4(10). e1000218–e1000218. 205 indexed citations
19.
Healy, Barry, Helen Stevens, Yanina Balabanova, et al.. (2006). Resequencing and association analysis of the SP110 gene in adult pulmonary tuberculosis. Human Genetics. 121(2). 155–160. 28 indexed citations
20.
Nikolayevskyy, Vladyslav, et al.. (2006). Molecular epidemiology and prevalence of mutations conferring rifampicin and isoniazid resistance in Mycobacterium tuberculosis strains from the southern Ukraine. Clinical Microbiology and Infection. 13(2). 129–138. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Kochi Breakdown of academic impact, for papers by Martin Dedicoat Breakdown of academic impact, for papers by M. Cristina Gutiérrez Breakdown of academic impact, for papers by Işık Somuncu Johansen Breakdown of academic impact, for papers by Brett Leav Breakdown of academic impact, for papers by Vladyslav Nikolayevskyy Breakdown of academic impact, for papers by Alice Zwerling Breakdown of academic impact, for papers by Satoshi Mitarai Breakdown of academic impact, for papers by Moisés Palaci Breakdown of academic impact, for papers by Alphonse Okwera
Rankless by CCL
2026